Analgo-sedation in intensive care: A quantitative, EEG-based trial with propofol 1% and 2%;Analgosedierung auf der intensivstation eine quantitative, EEG-gestutzte untersuchung mit propofol 1% und 2%

Anaesthesist

Volumn 48, Issue 11, 1999, Pages 794-801

  Albrecht, S ^a   Ihmsen, H ^a   Suchodolski, K ^a   Frenkel, C ^b   Schuttler J ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Municipal Hospital of Lueneburg   (Germany)

Author keywords

Alfentanil; Closed loop feedback control; EEG median frequency; Long term ICU sedation; Pharmacokinetics; Propofol

Indexed keywords

ALFENTANIL; LIPID; PROPOFOL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTINUOUS INFUSION; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG TOLERANCE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; INTENSIVE CARE; MALE; PHARMACODYNAMICS; SEDATION;

EID: 0033408547     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050787     Document Type: Article

References (31)

1. Adam HK, Douglas EJ, Plummer GF, Cosgrove MB (1981) Estimation of ICI 35,868 (Diprivan) in blood by high-performance liquid chromatography, following coupling with Gibb's reagent. J Chromatogra 223:232-237
2. Albanese J, Martin C, Lacarelle B, Saux P, Durand A, Gouin F (1990) Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients. Anesthesiology 73:214-217
3. Beal SL, Sheiner LB (1989) NONMEM User's Guide. University of California, San Francisco
4. Boyle WA, Shear JM, White PF, Schuller D (1991) Long-term sedative infusion in Intensive Care Unit: propofol versus midazolam. J Drug Dev [Suppl 3] 4:43-45
5. Buckley PM (1997) Propofol in patients needing long-term sedation in intensive care: an assessment of the development of tolerance. Intensive Care Med 23:969-974
6. Devandre J, van Bos R, van Hemelrijck J, Van Aken H (1994) Comparison of the 2% and 1% formulations of propofol during anaesthesia for craniotomy. Anaesthesia 49:8-12
7. Doenicke AW, Roizen MF, Rau J, O'Connor M, Kugler J, Klotz U, Babl J (1997) Pharmacokinetics and pharmacodynamics of propofol in a new solvent. Anesth Analg 85:1399-1403
8. Dutta S, Ebling WF (1998) Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats. J Pharm Pharmacol 50:37-42
9. Ewart MC, Yau KW, Morgan M (1991) Comparison of 1% and 2% formulations of propofol for sedation following cardiac surgery. J Drug Dev [Suppl 3] 4:59-61
10. Frenkel C, Schüttler J, Ihmsen H, Heye H, Rommelsheim K (1995) Pharmacokinetics and pharmacodynamics of propofol/alfentanil infusions for sedation in ICU patients. Intensive Care Med 21:981-988
11. Freye E, Neruda B, Falke K (1991) EEG power spectra and evoked potentials during alfentanil/midazolam analgesia-sedation in intensive care patients. Anästhesiol Intensivmed Notfallmed Schmerzther 26:384-388
12. Fulton B, Sorkin EM (1995) Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 4:636-657
13. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ, Barie PS, Rubin AL (1996) Low lipid concentrations in critical illness: implications for preventing and treating endotoxaemia. Crit Care Med 24:584-589
14. Gottardis M, Khünl-Brady KS, Koller W, Sigl G, Hackl JM (1989) Effect of prolonged sedation with propofol on serum triglyceride and cholesterol concentrations. Br J Anaesth 62:393-396
15. Harper SJ, Buckley PM, Carr K (1991) Propofol and alfentanil infusions for sedation in intensive therapy. Eur J Anaesthesiol 8:157-165
16. Jenkinson JL (1990) The monitoring of central nervous system function in anaesthesia and intensive care. Cur Anaesth Crit Care 1:115-121
17. Kharasch ED, Russell M, Mautz D, Thummel KE, Kunze KL, Bowdle A, Cox K (1997) The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions. Anesthesiology 87:36-50
18. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: A severity of disease classification system. Crit Care Med 13:818-829
19. Lutzenberger W, Elbert TH, Rockstroh B, Birbaumer N (1985) Das EEG. Psychophysiologie und Methodik von spontan-EEG und ereigniskorrelierten Potentialen. Springer, Berlin Heidelberg New York
20. Maitre PO, Vozen S, Heykants J, Thomson DA, Stanski DR (1987) Population pharmacokinetic of alfentanil: the average dose - plasma concentration relationship and interindividual variability in patients. Anesthesiology 66:3-12
21. McLeod G, Dick J, Wallis C, Patterson A, Cox C, Colvin J (1997) Propofol 2% in critically ill patients: effect on lipids. Crit Care Med 25:1976-1981
22. Niedermeyer E (1987) Metabolic central nervous system disorders. In: Niedermeyer E, Lopes da Silva (eds) Electroencephalography. Basic Principles, Clinical Applications and Related Fields. Urban & Schwarzenberg, Baltimore, pp 383-389
23. Ramsay MAE, Saege TM, Simpson BRJ, Goodwin R (1974) Controlled sedation with alphaxalone-alphadolone. Br Med J 280:658-659
24. Rechtschaffen A, Kales A (1968) A Manual of standardized terminology. Techniques and scoring system for sleep stages in human subjects. Public Health Service, U.S. Government Printing Office, Washington, DC
25. Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, Youngs EJ (1998) The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 88:1170-1182
26. Schüttler J, White PF (1984) Optimization of the radioimmunoassays for measuring fentanyl and alfentanil in human serum. Anesthesiology 61:86-93
27. Schüttler J, Schwilden H, Stoeckel H (1987) Pharmacokinetic and pharmakodynamic modelling of propofol (diprivan) in volunteers and surgical patients. Postgrad Med J [Suppl 3] 61:53-54
28. Schwilden H, Stoeckel H (1980) Untersuchungen über verschiedene EEG-Parameter als Indikatoren des Narkosezustands. Der Median als quantitatives Maß der Narkosetiefe. Anästh Inensivther Notfallmed 15:279-286
29. Schwilden H, Stoeckel H, Schüttler J (1989) Closed-loop feedback control of propofol anaesthesia by quantitative EEG analysis in humans. Br J Anaesth 62:290-296
30. Spencer EM, Green JI, Willatts SM (1994) Continuous monitoring of depth of sedation by EEG spectral analysis in patients requiring mechanical ventilation. Br J Anaesth 73:649-654
31. Veselis RA, Reinsel R, Marino P, Sommer S, Carlon GC (1993) The effects of midazolam on the EEG during sedation of critically ill patients. Anaesthesia 48:463-470